Introduction
The Saudi Arabian pharmaceutical sector is becoming increasingly
attractive for multinationals to enter driven by the expansion
of private healthcare and altering patient demographics; and
also for domestic generics companies as the government looks to
evolve its cost saving strategies.
Scope
- Overview of challenges faced by the Saudi Arabian healthcare
system and a review of the healthcare financing system reforms
- Analysis of trends observed in the pharmaceutical sector and
the development of the healthcare insurance sector
- Update of healthcare reforms undertaken in the Kingdom and
thought-leader insights into future changes to be implemented
- Commercial implications of the reforms for insurers,
multinational and domestic pharma companies, supported by
Datamonitor strategic recommendations
Highlights
Healthcare reforms in Saudi Arabia will increase access to
healthcare services and pharmaceuticals as the penetration of
cooperative health insurance increases across the Kingdom.
Datamonitor forecasts this will result in a significant increase
in overall expenditure on drugs; however there will be a greater
shift towards generics use.
As competition increases, insurers will attempt to increase
profits by implementing cost containment measures such as
pharmacoeconomic drug evaluations, generic substitution and
formulary lists. However, strong underwriting policies, optimal
pricing premiums, and delivering quality care to members will
remain critical.
Increasingly westernized lifestyles have driven up levels of
chronic disease, enhancing the need for drug intervention, with
lifestyle products dominating the retail market. Many branded
drugs despite their off patent status still command market
leading sales and positive growth, underlining the preference
for branded drugs in the Saudi market.
Reasons to Purchase
- Understand the Saudi healthcare market and the strategic
implications of future reforms and how these will affect your
business
- Identify opportunities for mutually beneficial relationships
between your firm and insurers which are becoming increasingly
powerful stakeholders
- Gain insight into investment opportunities and create
compelling cases for strategic changes in your organization to
adapt to the evolving market
